Bitwise MARA Option Income Strategy ETF (NYSEARCA:IMRA) Short Interest Up 30.1% in February

Bitwise MARA Option Income Strategy ETF (NYSEARCA:IMRAGet Free Report) saw a significant increase in short interest during the month of February. As of February 13th, there was short interest totaling 95 shares, an increase of 30.1% from the January 29th total of 73 shares. Currently, 0.0% of the company’s shares are sold short. Based on an average daily volume of 7,082 shares, the short-interest ratio is presently 0.0 days. Based on an average daily volume of 7,082 shares, the short-interest ratio is presently 0.0 days. Currently, 0.0% of the company’s shares are sold short.

Bitwise MARA Option Income Strategy ETF Stock Performance

Shares of IMRA stock traded up $0.14 on Monday, hitting $14.89. The company had a trading volume of 3,738 shares, compared to its average volume of 6,408. Bitwise MARA Option Income Strategy ETF has a twelve month low of $11.99 and a twelve month high of $60.73. The stock’s 50-day moving average is $15.32 and its two-hundred day moving average is $25.49. The firm has a market cap of $3.57 million, a P/E ratio of 297.80 and a beta of -6.67.

Bitwise MARA Option Income Strategy ETF Company Profile

(Get Free Report)

IMARA Inc, a clinical-stage biopharmaceutical company, develops and commercializes therapeutics for patients with rare genetic disorders of hemoglobin. Its lead product candidate is IMR-687, an oral and once-a-day therapeutic that is in Phase 2b clinical trials for the treatment of sickle cell disease and ß-thalassemia. The company also develops IMR-261, an oral and clinical-ready activator of nuclear factor erythroid 2–related factor 2 for the treatment of hemoglobinopathies, iron disorders, and potentially other areas.

Featured Articles

Receive News & Ratings for Bitwise MARA Option Income Strategy ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bitwise MARA Option Income Strategy ETF and related companies with MarketBeat.com's FREE daily email newsletter.